Despite its promising results, the study was not powered to address safety or efficacy end points.
Source DR. ANKER
My Take
'The Effect Occurs So Quickly'
This is a remarkable result. I am especially impressed that the separation in the primary end points between the patients receiving iron and those on placebo began to be statistically significant after the first 4 weeks on treatment and then continued to separate further.
The effect occurs so quickly. This is probably the fastest separation we've seen in a clinical trial in heart failure.
MILTON PACKER, M.D., is professor of medicine at the University of Texas Southwestern Medical Center in Dallas. He has been an adviser to Actelion, Pfizer, and United Therapeutics.
